Cytokinetics, Incorporated (CYTK) Balance Sheet
As of 2026-06-30 (10-Q), Cytokinetics, Incorporated (CYTK) reported total assets of $1.9B, total liabilities of $2.1B and shareholders' equity of -$173.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $255.3M. Long-term debt: $248.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CYTKCytokinetics, IncorporatedFollow CYTK — free
—
Price chart with a free account
- Market cap
- 8.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.07 | 0.13 | 0.04 | 0.04 | 0.08 | 0.11 | 0.07 | 0.11 | 0.09 | 0.12 | 0.26 | |
| Short-term investments | 0.03 | 0.06 | 0.06 | 0.06 | 0.05 | 0.09 | 0.14 | 0.16 | 0.19 | 0.38 | 0.36 | 0.72 | 0.50 | 0.98 | 0.76 | 0.91 | |
| Receivables | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.05 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |
| Current assets | 0.05 | 0.08 | 0.08 | 0.13 | 0.11 | 0.16 | 0.27 | 0.21 | 0.23 | 0.47 | 0.54 | 0.80 | 0.63 | 1.11 | 0.92 | 1.21 | |
| Total assets | 0.05 | 0.08 | 0.08 | 0.13 | 0.12 | 0.17 | 0.29 | 0.21 | 0.29 | 0.53 | 0.84 | 1.01 | 0.82 | 1.40 | 1.42 | 1.92 | |
| Current liabilities | 0.00 | 0.01 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.07 | 0.08 | 0.10 | 0.18 | 0.20 | 0.18 | |
| Long-term debt | — | — | — | 0.00 | 0.01 | 0.03 | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.09 | 0.25 | 0.25 | |
| Short-term debt | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.01 | 0.01 | 0.04 | 0.03 | |
| Total liabilities | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 | 0.08 | 0.18 | 0.19 | 0.30 | 0.42 | 0.60 | 1.12 | 1.21 | 1.54 | 2.08 | 2.10 | |
| Shareholders' equity | 0.05 | 0.07 | 0.05 | 0.09 | 0.07 | 0.09 | 0.11 | 0.03 | -0.01 | 0.11 | 0.24 | -0.11 | -0.39 | -0.14 | -0.66 | -0.17 |
USD billions · SEC XBRL
Cytokinetics, Incorporated — questions
- How much cash does Cytokinetics, Incorporated have?
- $255.3M in cash and cash equivalents as of 2026-06-30.
- How much debt does Cytokinetics, Incorporated have?
- $248.2M of long-term debt and $27.4M due within a year as of 2026-06-30.
- What are Cytokinetics, Incorporated's total assets?
- $1.9B as of 2026-06-30.
- What is Cytokinetics, Incorporated's shareholders' equity?
- -$173.5M as of 2026-06-30.
Every figure on this page comes from Cytokinetics, Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.